Daily LXR agonist treatment protected mice from DAH and promoted M2 repolarization of CD138+ Mφ (Figure 5), suggesting that M1 Mφ play a role in SLE-associated DAH. The gene discussed is SDC1; the disease is systemic lupus erythematosus.